FIG. 1.

Infection profiles of GBV-B infected tamarins. (A) Progress of initial GBV-B infection in tamarins 12024 (top) and 12026 (bottom). GBV-B levels are shown in comparison to the liver damage, as measured by ALT, and rise in serum antibody titers to the GBV-B NS3 protein over the 24- to 26-week course of the experiment. (B) GBV-B levels and serum antibody titers to the NS3 protein during the course of rechallenge infection of 12024 (top) and 12026 (bottom) with a standard inoculum of GBV-B-containing 12024 tamarin serum. GBV-B TaqMan data, measured in genome equivalents per milliliter of serum, are shown as bar graphs, with line graphs representing ALT and NS3 ELISA absorbance superimposed.